baber/WOPTO huggingface dataset:
Patent MX-2020005724-A (MX)
Title: Alpha-amylase variants and polynucleotides encoding same.
Inventor: ANDERSEN CARSTEN
IPC: C12N9/28
Filed: 2018-12-07
Abstract: The present invention relates to alpha-amylase variants comprising substitutions at positions corresponding to positions 268 and 293 of SEQ ID NO: 1, in particular substitutions selected from the group consisting of: 268G+293Y; 268G+293F; 268G+293W; 268G+293H; 268G+293A; 268G+293Q; 268A+293Y; 268A+293F; 268A+293W; 268A+293H; 268A+293A; 268A+293Q; 268P+293Y; 268P+293F; 268P+293W; 268P+293H; 268P+293A; 268P+293Q; 268S+293Y; 268S+293F; 268S+293W; 268S+293H; 268S+293A; 268S+293Q; 268T+293Y; 268T+293F; 268T+293W; 268T+293H; 268T+293A; 268T+293Q; 268V+293Y; 268V+293F; 268V+293W; 268V+293H; 268V+293A; 268V+293Q; 268I+293Y; 268I+293F; 268I+293W; 268I+293H; 268I+293A; 268I+293Q; 268L+293Y; 268L+293F; 268L+293W; 268L+293H; 268L+293A; 268L+293Q; 268M+293Y; 268M+293F; 268M+293W; 268M+293H; 268M+293A; 268M+293Q;, and wherein the variant has at least 70%, at least 75%, at least 80%, at least 85%, at least 90%, at least 95%, at least 96%, at least 97%, at least 98%, or at least 99%, but less than 100% sequence identity to a parent alpha amylase selected from the group consisting of SEQ ID NO: 1, SEQ ID NO: 2, SEQ ID NO: 3, SEQ ID NO: 4, and SEQ ID NO: 18. The present invention also relates to polynucleotides encoding the variants; nucleic acid constructs, vectors, and host cells comprising the polynucleotides; and methods of using the variants.
Patent MX-2020009785-A (MX)
Title: Multilayer constrained-layer damping.
Inventor: GANESAN MAHESH
IPC: B32B25/08
Filed: 2018-03-19
Abstract: Provided herein is are multilayer damping laminates comprising alternating damping and constraining layers. The materials and configurations of the damping layers are selected such that the damping layers have a decreasing glass transition temperature profile beginning at the first damping layer, allowing the laminates to effectively dissipate vibrations over a wider range of operating temperatures and/or frequencies. Also provided are systems and methods using the multilayer damping laminates.
Patent MX-2020011136-A (MX)
Title: An automatic process for generating accounting policies, bank conciliation, flows, vat summary, and informatie declaration of operations with thurd parties reports from the statements sent by the bank.
Inventor: FLORES ALMENDARIZ CESAR GERARDO
IPC: G06Q40/00
Filed: 2020-10-21
Abstract: The present invention relates to an automatic process for generating accounting policies, bank reconciliation, flows, VAT summary, and reports of the Informative Declaration of Operations with Third Parties directly from the files sent by the banks containing the statements at a certain date or for full months. It aims to facilitate the generation of the accounting of bank operations together with their reconciliation directly from the bank file.
Patent MX-2020014218-A (MX)
Title: Method for treating a foundry sand mixture.
Inventor: MOKRE ALEXANDER
IPC: B22C5/04
Filed: 2019-07-01
Abstract: The invention relates to a method for the cost-effective, resource-saving and highly-productive recovery of moulding sand (F) from a foundry sand mixture (G) containing at least a portion (FAB) of fragments or loose particles of moulding material produced during the demoulding of a cast part from a casting mould as a result of the destruction of mould cores or mould parts forming the cast part, which have been formed from the moulding sand (F) and an inorganic binder and optionally at least one additive for controlling the properties of the moulding material, wherein the method comprises the working steps of a) mixing the foundry sand mixture (G) with cleaning water (RW) to form a slurry (S) in order to remove the inorganic binder residues (AB) contained in the foundry sand mixture (G) and optionally present additives from the moulding sand (F) and to wash them out of the foundry sand mixture (G), and b) separating the cleaning water (RWK) contaminated with the inorganic binder residues (AB) from the moulding sand (F) contained in the slurry (S), and wherein the process temperature of the slurry (S) formed from the cleaning water and the foundry sand mixture (G) (working step a)) is between 50 and 200Â°C.
Patent MX-2021001019-A (MX)
Title: Oligonucleotides comprising a phosphorotrithioate internucleoside linkage.
Inventor: BLEICHER KONRAD
IPC: A61P9/00
Filed: 2019-07-30
Abstract: The present invention relates to an oligonucleotide comprising at least one phosphorotrithioate internucleoside linkage of formula (I), wherein (A<sup>1</sup>), (A<sup>2</sup>) and R are as defined in the description and in the claim. The oligonucleotide of the invention can be used as a medicament.
Patent MX-2021003842-A (MX)
Title: Combination therapy for the treatment of cancer.
Inventor: THAKURTA ANJAN
IPC: C07K16/28
Filed: 2019-09-30
Abstract: Provided herein are methods of treating and/or managing cancers, which comprise administering to a patient Compound A, or an enantiomer or a mixture of enantiomers thereof, or a pharmaceutically acceptable salt, solvate, hydrate, co-crystal, clathrate, or polymorph thereof in combination with daratumumab. Additionally, provided herein are methods of treating and/or managing cancers, which comprise administering to a patient Compound A, or an enantiomer or a mixture of enantiomers thereof, or a pharmaceutically acceptable salt, solvate, hydrate, co-crystal, clathrate, or polymorph thereof in combination with daratumumab and dexamethasone.
Patent MX-2021003979-A (MX)
Title: Non-uniform artificial turf infill.
Inventor: STOFFER ERIC
IPC: D01F6/46
Filed: 2019-10-08
Abstract: An artificial turf simulating grass including a layer of dispersed non-uniform, polyvinyl chloride-based particulates having non-symmetrical shapes and different sizes.
Patent MX-2021006238-A (MX)
Title: Methods for treatment using adoptive cell therapy.
Inventor: ALBERTSON TINA
IPC: A61P35/00
Filed: 2019-11-29
Abstract: Provided are adoptive cell therapy involving the administration of doses of cells for treating subjects with disease and conditions such as certain B cell malignancies, and related methods, compositions, uses and articles of manufacture. The cells generally express recombinant receptors such as chimeric antigen receptors (CARs). In some embodiments, the disease or condition is a large B cell lymphoma, such as a diffuse large B-cell lymphoma (DLBCL). Also provided are methods of assessing the risk of developing a toxicity related to a cell therapy, and methods of identifying subjects and methods of treating subjects based on the assessment of risks.
Patent MX-2021006428-A (MX)
Title: Anti-claudin 18.2 and anti-4-1bb bispecific antibodies and uses thereof.
Inventor: FANG LEI
IPC: A61P35/00
Filed: 2020-08-12
Abstract: Provided are bispecific and multi-specific antibodies that target both claudin 18.2 (CLDN18.2) and 4-1BB. These antibodies, in the absence of CLDN18.2-expressing cells, can bind to 4-1BB but are unable to activate 4-1BB signaling. In the presence of CLDN18.2-expressing cells, however, these antibodies can trigger CLDN18.2-dependent 4-1BB signaling, leading to potent immune response to the CLDN18.2-expressing tumor cells.
Patent MX-2021007271-A (MX)
Title: New conjugated nucleic acid molecules and their uses.
Inventor: SPROAT BRIAN
IPC: A61P35/00
Filed: 2019-12-20
Abstract: The present invention relates to new nucleic acid molecules of therapeutic interest, in particular for use in the treatment of cancer.
Patent MX-2021010739-A (MX)
Title: Immunomodulating mesenchymal stem cells.
Inventor: SPAAS JAN
IPC: C12N5/0775
Filed: 2020-03-12
Abstract: The current invention concerns an isolated mesenchymal stem cell wherein said cell is measuredpositive for mesenchymal markers CD29, CD44 and CD90; and negative for MHC class II molecules,whereinsaid cell secretes immunomodulatory prostaglandin E2 cytokine when present in an inflammatory environment or condition.The current invention also concerns a cell composition comprising said cells and the use thereof in the treatment of immune-related diseases and inflammatory conditions.
Patent MX-2021013210-A (MX)
Title: Strength enhancer for concretes based on functionalized nanomaterials.
Inventor: GUERRERO NAYIBE
IPC: C04B14/02
Filed: 2020-05-28
Abstract: The present invention describes an admixture for cement based compositions, the admixture comprising a) an aqueous solution of polycarboxylate ether and b) at least one functionalized nanomaterial selected from carbon nanotubes functionalized by carboxyl groups and carbon nanofibers functionalized by carboxyl groups, wherein the at least one functionalized nanomaterial is dispersed in the aqueous solution. Low dosages of the admixture in cement based compositions result in significant enhancement of compressive strength.
Patent MX-2022001691-A (MX)
Title: Coating compositions, layers, and systems for radar transmission and methods for making and using the same.
Inventor: DECKER ELDON L
IPC: C09D7/40
Filed: 2020-08-07
Abstract: A coating composition, a coating layer, and a coating system, and a method for making a and using the same are provided. The coating system comprises a flop index of 2 or greater and comprises a coating layer formed by a coating composition. The coating composition comprises a film-forming resin and a pigment composition. The pigment composition comprises 50% or greater by weight radar transmissive pigment based on the total weight of the pigment composition and no greater than 50% by weight electrically conductive pigment based on the total weight of the pigment composition. The coating system has a radar signal transmission of 70% or greater. The coating system has a CIELAB color difference, ÎE, compared to a color-matched coating system of no greater than 4, as measured at 110Â°, using a multi-angle spectrophotometer with D65 Illumination and 10Â° observer.
Patent MX-2022002193-A (MX)
Title: Novel peptides and scaffolds for use in immunotherapy against head and neck squamous cell carcinoma and other cancers.
Inventor: WEINSCHENK TONI
IPC: C07K14/47
Filed: 2019-02-20
Abstract: The present invention relates to peptides, proteins, nucleic acids and cells for use in immunotherapeutic methods. In particular, the present invention relates to the immunotherapy of cancer. The present invention furthermore relates to tumor-associated T-cell peptide epitopes, alone or in combination with other tumor-associated peptides that can for example serve as active pharmaceutical ingredients of vaccine compositions that stimulate anti-tumor immune responses, or to stimulate T cells ex vivo and transfer into patients. Peptides bound to molecules of the major histocompatibility complex (MHC), or peptides as such, can also be targets of antibodies, soluble T-cell receptors, and other binding molecules.
Patent MX-2022004733-A (MX)
Title: Method and apparatus for displaying live clip.
Inventor: TAN PEIQIANG
IPC: H04N21/44
Filed: 2022-04-20
Abstract: The present disclosure relates to a method for displaying a live clip. The method includes: receiving first request information sent by a client, the first request information including an identifier of the live clip; acquiring the live clip corresponding to the identifier of the live clip, the live clip including an identifier of a live stream and a timestamp of the live clip; acquiring an interactive message corresponding to the identifier of the live clip, the interactive message including the identifier of the live stream and a timestamp of the interactive message; and sending the live clip and the interactive message to the client, to enable the client to display the live clip and the interactive message based on the identifier of the live stream, the timestamp of the live clip and the timestamp of the interactive message.
Patent MX-2022006889-A (MX)
Title: Vulcanisation process and apparatus for tyres.
Inventor: MORRONE GIUSEPPE
IPC: B29D30/06
Filed: 2020-11-27
Abstract: Heat is supplied to a tyre (2) closed in a vulcanisation mould (3) in order to determine the vulcanisation thereof. During the heat supplying, the cross-linking degree reached in at least one detection zone (14a, 15a, 18a, 19a) located within the tyre (2) is monitored, in order to interrupt the heat supplying when the cross-linking degree reaches a predetermined reference value. An actual vulcanisation time, running between the beginning and the interruption of the heat supplying, is compared with a preset nominal vulcanisation time. When the difference between the actual vulcanisation time and the nominal vulcanisation time exceeds at least one predetermined attention threshold, a warning signal is recorded. Upon repeating a predetermined number of recorded warning signals, the operating temperature of the heating fluid is modified, in order to modify the actual vulcanisation time in the subsequent vulcanisation cycles.
Patent MX-2022009924-A (MX)
Title: Quick disconnect torch handle.
Inventor: RAYMOND ANDREW J
IPC: H05H1/34
Filed: 2019-05-07
Abstract: Provided herein is a quick disconnect torch handle (12) for use in a plasma arc system (1). In one approach, the plasma arc system (1) includes a lead (6) having a first end (3) connected to a power source (2) and a second end (7) connected to a torch handle (12). The quick disconnect (16) is located at a proximal end (22) of the torch handle (12), and may include at least one signal connection, a pilot connection, a fluid connection, and a main power connection. The fluid and main power connection may be formed by a connection between a main power socket (37) and a conductive conduit (33). Specifically, the main power socket (37) includes a conductive spring (40) and an O-ring (41) encircling an interior bore (42) thereof. Removal of the conductive conduit (33) from the main power socket (37) causes the fluid connection to break between the O-ring (41) and the conductive conduit (33), and then the main power connection to break between the conductive spring (40) and the conductive conduit (33).
Patent MX-2022009935-A (MX)
Title: Terminal, radio communication method, and base station.
Inventor: NAGATA SATOSHI
IPC: H04W16/28
Filed: 2020-02-14
Abstract: A terminal according to one embodiment of the present disclosure includes: a control unit which, on the basis of whether antenna port switching between arbitrarily defined antenna port pairs is supported, determines a correspondence relationship between the bits in Transmitted Precoding Matrix Indicator (TPMI) group capability information and TPMI groups; and a transmitting unit which transmits the TPMI group capability information corresponding to a TPMI group that supports full-power transmission, on the basis of the correspondence relationship. This embodiment of the present disclosure makes it possible to control full-power transmission appropriately.
Patent MX-2022010224-A (MX)
Title: Compounds that interact with the ras superfamily for the treatment of cancers, inflammatory diseases, rasopathies, and fibrotic disease.
Inventor: HADARI YARON R
IPC: C07D495/04
Filed: 2019-12-10
Abstract: Provided herein are methods and compositions for treating cancers, inflammatory diseases, rasopathies, and fibrotic disease involving aberrant Ras superfamily signaling through the binding of compounds to the GTP binding domain of Ras superfamily proteins including, in certain cases, K-Ras and mutants thereof, and a novel method for assaying such compositions.
Patent MX-2022013808-A (MX)
Title: Triple combination therapy for enhancing cancer cell killing in cancers with low immunogenicity.
Inventor: HUANG LAN
IPC: A61K31/496
Filed: 2021-04-30
Abstract: Disclosed herein are composition and methods of treating a condition where enhanced immunogenicity is desired. Some embodiments disclosed herein relate to compositions comprising a T-cell activator and/or proliferator, one or more immune checkpoint inhibitor, and a FPPS inhibitor. Some embodiments relate to methods of treating cancer by co-administering plinabulin, one or more immune checkpoint inhibitor, and a FPPS inhibitor to a subject in need thereof.
Patent MX-2022015040-A (MX)
Title: Engineered coronavirus spike (s) protein and methods of use thereof.
Inventor: MCLELLAN JASON
IPC: A61K39/12
Filed: 2021-05-28
Abstract: Provided herein are engineered Coronavirus S proteins, such as engineered SARS-CoV-2 S proteins. In some aspects, the engineered S proteins exhibit enhanced conformational stability and/or antigenicity. Methods are also provided for use of engineered proteins as diagnostics, in screening platforms and/or in vaccine compositions.
Patent MX-PA01008204-A (MX)
Title: Stationary tissue dispenser.
Inventor: THOMAS G SHANNON
IPC: A47K10/32
Filed: 2001-08-14
Abstract: A tissue container having a plurality of walls and a contact surface is capable of dispensing tissues to users. The container may be removably affixed to an object or surface such that it resists movement when a tissue is pulled from the container. The container may have an adhesive on its contact surface. The adhesive may be exposed by removing a protective covenng or layer from the contact surface of the container. A dispensing surface provides an opening through which tissues are dispensed.
Patent MX-PA01013268-A (MX)
Title: Printed wiring board and method for manufacturing printed wiring board.
Inventor: KOJI KONDO
IPC: B29L9/00
Filed: 2001-12-18
Abstract: Conductive paste containing tin particles and silver particles is packed in a substantially cylindrical via hole formed in a thermoplastic resin film that interposes between conductor patterns and is hot-pressed from both sides. When the metal particles contained in the conductive paste are sintered to form a unified conductive compound, the volume of the conductive paste shrinks. Synchronously, the resin film around the via-hole protrudes into the via-hole. Therefore, the shape of the side wall on the cross-section of the conductive compound provides an arch shape, and a side wall adjacent to a junction part of the conductive compound, which contacts the conductor pattern, is formed with an inclination. Therefore, it is possible to prevent the stress concentration due to deformation of the board.
Patent MX-PA02002947-A (MX)
Title: Method for measuring changes in portions of a human body.
Inventor: WARREN WALLO
IPC: A61Q19/00
Filed: 2002-03-14
Abstract: A method for measuring changes in a portion of a human body including: obtaining a first three-dimensional image of the portion of a human body; treating the portion of a human body to create changes therein; obtaining a second three-dimensional image of the portion of a human body so treated; overlaying the first three-dimensional image and the second three-dimensional image; and comparing the first and second images to measure changes in the portion of a human body is disclosed. The method is particularly useful for demonstrating and measuring changes to the face achieved through the use of cosmetics. Typical changes include lifting of the face, contouring the face and reduction of wrinkles.
Patent MX-PA02003488-A (MX)
Title: Two camera off axis eye tracker.
Inventor: MUNNERLYN CHARLES R
IPC: A61N5/06
Filed: 2000-10-05
Abstract: Improved laser eye surgery and or eye tracking systems, methods, and devices make use of two image capture devices (13), generally with both image capture devices disposed off the optical axis of the eye and or any laser delivery system (28). This provides an enhanced imaging contrast for an imaging capture device such as a camera with a charge couple device (CCD), particularly when using infrared imaging to track a pupil of the eye. The two off axis cameras may be used independently to track movements of the pupil along two orthogonal lateral axes of the eye (often called X Y tracking), and may also indicate a position of the eye along the optical or Z axis.
Patent MX-PA02006533-A (MX)
Title: Biodegradable nonwoven webs for fluid management.
Inventor: WERTHEIM BRIGITTE C
IPC: D04H1/42
Filed: 2000-12-14
Abstract: Nonwoven webs for use as the surge layer of personal care articles are provided. The webs include a first, binder fiber, which is a biodegradable thermoplastic fiber that does not undergo severe heat shrinkage. The webs further include a second fiber which is a biodegradable, high tenacity cellulosic fiber. The first and second fibers are combined to form a web that has a moderate permeability, in the range of 500 to 1500 mgr;m2, and a high void volume, greater than 25 cm3g.
Patent MX-PA02011936-A (MX)
Title: Air-purifying and contaminant wastes retainer hood for integral kitchens.
Inventor: GUERRERO PENA VICTOR HUGO
IPC: B08B15/00
Filed: 2002-12-02
Abstract: The present refers to an air-purifying and contaminant wastes retainer hood for integral kitchens with disposition of parts placed in different fashion comprising a black sheet irregular box, some grooves by which polluted air or gases flow out, some actuating and lightening buttons with their connections, a filter with a single filtrating layer, some filter fastening knobs, a plastic cover for light bulb protection and in the interior of the hood, an actuating motor with its respective blades and support, said hood is characterized because the motor adopts an opposite position to the position of the motor in the current hoods, this new position allows an approximation of the motor and its blades to the filter which allows avoiding the pressure opposition or falling in the air filter; with the current position, the turning speed is slower offering only a 35% of polluted air or gases exhaustion against a 65% achieved with the new motor disposition which turns faster.
Patent MX-PA03001762-A (MX)
Title: Process for preparing pharmaceutical compositions for use with soft gelatin formulations.
Inventor: TINDAL STEPHEN CHARLES
IPC: A61K9/48
Filed: 2001-08-28
Abstract: The invention disclosed herein is a process for increasing the achievable concentration of a pharmaceutically active ingredient relative to fill composition viscosity for dosage units. The process is particularly useful in the preparation of soft gelatin capsules containing ibuprofen, naproxen, indomethacin, and acetaminophen, as the pharmaceutically active ingredient. As a result of the process, lesser quantities of composition ingredients other than the pharmaceutically active ingredient are needed to accomplish the same therapeutically effective dosage, thereby significantly increasing the concentration of the pharmaceutically active ingredient resulting in either a reduction in overall fill volume and dosage unit size or an increase in concentration of pharmaceutically active ingredient per dosage form.
Patent MX-PA03006344-A (MX)
Title: Computer-directed assembly of a polynucleotide encoding a target polypeptide.
Inventor: GLEN A EVANS
IPC: G16B30/20
Filed: 2002-01-18
Abstract: The present invention outlines a novel approach to utilizing the results of genomic sequence information by computer-directed polynucleotide assembly based upon information available in databases such as the human genome database. Specifically, the present invention may be used to select, synthesize and assemble a novel, synthetic target polynucleotide sequence encoding a target polypeptide. The target polynucleotide may encode a target polypeptide that exhibits enhanced or altered biological activity as compared to a model polypeptide encoded by a natural (wild-type) or model polynucleotide sequence.
Patent MX-PA03008736-A (MX)
Title: (p-amino-hydroxyphenyl)-acrylamide derivatives and dyes containing said compounds.
Inventor: LAURENT CHASSOT
IPC: D06P1/32
Filed: 2001-10-19
Abstract: The object of the invention are (p-aminohydroxyphenyl)acrylamide derivatives of general formula (I) or the physiologically tolerated, water-soluble salts thereof and oxidative coloring agents for keratin fibers, containing these compounds.